Real-time enrollment status for this atrial fibrillation clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 7:11 AM UTC
| NCT Number | NCT06716021 |
| Recruiting Status | Recruiting |
| Condition | Atrial Fibrillation |
| Phase | PHASE3 |
| Target Enrollment | 750 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Milestone Pharmaceuticals Inc. |
| Last Updated on CT.gov | October 7, 2026 (1 week ago) |
As of October 16, 2026: Clinical trial NCT06716021 is currently recruiting participants. This phase3 study for atrial fibrillation is actively seeking new participants at 4 locations across the United States. The study is sponsored by Milestone Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06716021 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06716021 was last updated 1 week ago (October 7, 2026). HelloStudys verifies this status automatically.